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Abstract: Ratios of equilibrium solubilities rarely exceed two-fold for polymorph pairs. A model
has been developed based on two intrinsic properties of polymorph pairs, namely the ratio of
equilibrium solubilities of the individual pairs (C*me/C*st) and the ratio of interfacial energies (γst/γme)
and one applied experimental condition, namely the supersaturation identifies which one of a pair of
polymorphs nucleates first. A domain diagram has been developed, which identifies the point where
the critical free energy of nucleation for the polymorph pair are identical. Essentially, for a system
supersaturated with respect to both polymorphs, the model identifies that low supersaturation with
respect to the stable polymorph (Sst) leads to an extremely small supersaturation with respect to
the metastable polymorph (Sme), radically driving up the critical free energy with respect to the
metastable polymorph. Generally, high supersaturations sometimes much higher than the upper
limit of the metastable zone, are required to kinetically favour the metastable polymorph.
Keywords: classical nucleation theory; polymorphs; interfacial energy; solubility; supersaturation;
metastable zone width
1. Introduction
This work follows the report of Abramov that, with some exceptions, the ratio of equilibrium
solubilities is less than 2.0 for 95% of polymorph pairs, based on a selection of 153 polymorph pairs [1].
Exceptionally, in the case of Ritonavir the reported solubility difference was 4–5 fold [2]. Although
well-documented and generally agreed upon, this phenomenon has not been addressed apart from a
previous publication from our group [3], which should be read as a companion paper.
Nyman and Day and separately Cruz-Cabeza, Reutzel-Edens and Bernstein have reported that the
lattice energy difference for over 700 polymorph pairs rarely exceeds 5–6 kJ mol−1 with the difference
for conformational polymorphs extending to 9–10 kJ mol−1 [4,5].
One further factor is the limited amount of energy available in solution crystallisations (RTlnS) [6,7]
which rarely exceeds 4–6 kJ mol−1 when typical supersaturation is employed.
Considering the energies involved and the sheer number of polymorph pairs in the studies cited
above we conclude that the measured equilibrium solubility ratio limit (2-fold) and the calculated
lattice and free energy limits (5–10 kJ mol−1) for polymorph pairs are different manifestations of the
same phenomenon.
The classical nucleation theory (CNT) describes nucleation rates as:
J = A exp (− ∆G∗c/RT) (1)
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The CNT expresses critical nucleation free energy (∆G∗c ) as follows:
∆G∗c =
16piNaγ3v2m
3k2T2ln2S
(2)
where γ is the interfacial energy, k is the Boltzmann constant, Na is Avogadro’s number, S is the
supersaturation, vm is the molar volume and T is the temperature (in Kelvin).
Both the exponential and pre-exponential factors in Equation (1) have been considered by in
assessing nucleation rates [8–11]. For example, Bernstein et al. [9] assessed a range of possible nucleation
rates for pair of polymorphs at supersaturations where the rate of formation of the metastable polymorph
can be identical to that of the stable polymorph, during concomitant polymorph occurrences. This
approach was further analysed by Teychene and Biscans for two polymorphs of Eflucimibe [12].
Other approaches to the question of polymorph selection include that of Black et al. [13], who
modelled the nucleation and growth rates with application to dimorphic p-aminobenzoic acid.
The model predicts that the polymorph with higher nucleation or growth will predominate.
A different approach by Stranski and Totomanow predicts that the formation of the metastable
polymorphs is driven by its lower critical free energy in comparison to the corresponding stable
polymorph [14,15]. Monomorphic compounds are those where the stable form has the lowest critical
free energy of nucleation [3].
Recent work by Horst et al. [16,17] have developed the theory of polymorph selection control
through a single nucleation event. They presented nucleation of pure form (metastable or stable) of
isonicotinamide upon crystallisation in small volumes from ethyl acetate solution. The single nucleus
then acted as a seed and the corresponding polymorph proliferated in the solution via a secondary
nucleation mechanism. Seed directed selection of polymorphic form was presented by Maher et al. [18]
on the industrial scale for piroxicam.
Secondary nucleation or crystal breeding theory has also been developed by other workers. This
theory is a two-step mechanism, where firstly, a liquid like structure formed in solution forms a weakly
bound crystallite on coming into contact with a seed crystal. Secondly, this crystallite detached form
the seed surface and itself acts a seed crystal [19,20]. Most recently Steendam et al. [21] have proved
experimentally that the single nucleation mechanism in combination with secondary nucleation is also
observed in large crystallisers.
This contribution will focus on the term ∆G*c in Equation (2) for pairs of polymorphs and explores
the relationship between supersaturation and two inherent characteristics of polymorph pairs, namely
the interfacial energies ratio (γst/γme) and the equilibrium solubilities ratio (C*me/C*st). These factors
together with molecular volume (which we assume is equal for pairs of polymorphs) determine the
relative sizes of ∆G*c for the pairs of polymorphs. This theory is justified on the basis of secondary
nucleation hypothesis [22] combined with the single nucleation event theory [17]. Implicit in this
approach is that once the first nucleus is formed, it acts as a seed for the rapid formation of numerous
other nuclei of the same polymorph corresponding to most of the crystallisable mass in the crystalliser.
Justification for this approach is the often report observation from the multi-vial approach to assessing
nucleation rates that the transformation from clear to cloud point is almost instantaneous with the
immediate formation of most of the crystallisable mass inside the vial. In particular, this approach will
be used to explore reasons why the experimentally observed equilibrium solubility ratios of pairs of
polymorphs rarely exceed 2. This approach is useful in determining which one of a pair of polymorphs
will appear first but it cannot predict the rate at which a metastable polymorph will transform into a
stable form.
Below we fully recognise the limitations of the CNT. In particular, the interfacial energy term
therein and the manner in which it is commonly measured refers to a mature large crystal face. It does
not take into account changes in interfacial energy as the crystal matures from a pre-critical size through
a transition state energy maximum and into a mature crystal. It does not take into account the changes to
interfacial energy as the shape or the exposed facets of the crystal change as the nucleus grows. Clearly,
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these may be important factors in determining the critical free energy of nucleation and in particular the
differing facets offered by different polymorphs must be reflected in the measured interfacial energies
cited below. This work takes as its starting point the reported experimental interfacial energies for a
number of polymorph pairs and seeks to establish a reasonable range of interfacial energy ratios of the
stable and metastable polymorphs as a basis for the establishment of the relative sizes of the critical
free energies of nucleation of polymorph pairs.
2. Materials and Methods
Interfacial energies for organic compounds in a range of solvents vary in the range 0.3 to 10 mJ m−2,
but values as high as 40 mJ m−2 have been reported [23–26]. A limited range of interfacial energies are
available for polymorph pairs. Teychene et al. have reported values of γme and γst for Eflucimibe in
Ethanol/heptane as 4.2 and 5.2 mJ m−2 respectively, giving a γst/γme ratio of 1.2 at 308 K [27]. Su et al.
reported values of γme and γst for d-Mannitol in water 1.8 and 3.2 mJ m−2 respectively, giving a γst/γme
ratio of 1.8 [28]. The solubility ratio at 293 K was reported as 1.40. For Glycine, Renuka Devi et al. have
reported interfacial energies in the range 5.7 to 8.4 mJ m−2 for the metastable beta polymorph and in
the range 11.5 to 22.2 mJ m−2 for the more stable alpha polymorph [29]. The solubility ratio at 298 K
was reported as 1.45. These reported values are useful in setting the range, especially of interfacial
energy ratios for our modelling below.
For convenience below pairs of polymorphs will be referred to as metastable and stable and the
corresponding subscripts to C and γ are me and st, respectively. Choice of metastable and stable are
based on the conventional practice that the metastable polymorphs exhibits the higher solubility for a
given set of conditions and the stable polymorph exhibits the lower solubility.
Below supersaturation (Sst) will be defined with respect to the stable form, namely C/C*st. Sme can
be readily calculated as
Sme = Sst/(C∗me/C∗st) (3)
The values of ∆G*c are expressed as kJ (mol clusters)−1 for the metastable (∆G*c me) and stable
polymorphs (∆G*c st). In developing the model, it will be assumed that γme is lower than γst consistent
with the literature data presented above. A feature of this work is that the polymorph pairs are
monotropic for the conditions explored and that C/C*me < C/C*st.
3. Results and Discussion
Figure 1 presents a composition of calculations of critical free energies of nucleation for pairs
of polymorphs covering a wide range of equilibrium solubility ratios (C*me/C*st), interfacial energies
(γst/γme) and applied supersaturations (calculated with respect to the stable polymorph (Sst). Figure 1A
clearly shows that when the solubility ratio is close to unity the critical free energy of nucleation is
always lower for the metastable polymorph, so we would expect that the metastable polymorph would
appear first for all applied supersaturations. Of course, it may transform rapidly or otherwise into the
stable polymorph. As we move towards higher solubility ratios (C*me/C*st = 2.22 in Figure 1B) we can
identify the lower applied supersaturations where the critical free energy of nucleation is lower for the
stable polymorph than the metastable. Figure 1C illustrates the influence of the ratio of solid–liquid
interfacial energies (γst/γme) on the critical free energies of nucleation of polymorph pairs. At low
interfacial energy ratios, the stable polymorph is favoured, whereas at high ratios the metastable
polymorph is favoured. The point of intersection in Figure 1C moves sharply to lower γst/γme values
as the supersaturation is increased. In general, higher supersaturation favour first appearance of the
metastable polymorph.
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Nucleation Free Energies (ΔG*c) for C*me/C*st =1.05 (A), C*me/C*st =2.22 (B), Temperature 293 K; γme =4 
mJ m−2; γst = 5.5 mJ m−2; γst/γme = 1.375; Vm =3.5 × 10−28 m3 molec−1, (C) Influence of Interfacial Energy 
Ratio (γst/γme) on the Critical Nucleation Free Energies (ΔG*c) for the Stable and Metastable 
Polymorphs. γme = 4 mJ/m2; C*me/C*st = 2.0; Temperature 293 K; Sst = 3.0; Vm =3.5 × 10−28 m3 molec−1 [3]. 
More generally, we can readily identify combinations of the solubility and interfacial energy 
ratios where the critical free energy of the stable polymorph becomes lower than the corresponding 
value for the metastable polymorph. Both of these factors are inherent properties of individual 
polymorph pairs. Control of the relative size of the critical free energies of nucleation for the pairs 
comes about through selection of an appropriate supersaturation, with higher values generally 
favouring the metastable polymorph. Figure 2 shows a schematic of how the values of Sme change as 
Sst increases from nominal values of 3 to 7. When Sst is equal to 3 the corresponding value for Sme is 
Figure 1. (A,B): Influence of Supersaturation with respect to the Stable Polymorph (Sst) on the
Critical Nucleation Free Energies (∆G*c) for C*me/C*st = 1.05 (A), C*me/C*st = 2.22 (B), Temperature
293 K; γme = 4 mJ m−2; γst = 5.5 mJ m−2; γst/γme = 1.375; Vm =3.5 × 10−28 m3 molec−1, (C)
Influence of Interfacial Energy Ratio (γst/γme) on the Critical Nucleation Free Energies (∆G*c) for
the Stable and Metastable Polymorphs. γme = 4 mJ/m2; C*me/C*st = 2.0; Temperature 293 K; Sst = 3.0;
Vm =3.5 × 10−28 m3 molec−1 [3].
More generally, we can readily identify combinations of the solubility and interfacial energy ratios
where the critical free energy of the stable polymorph becomes lower than the corresponding value for
the metastable polymorph. Both of these factors are inherent properties of individual polymorph pairs.
Control of the relative size of the critical free energies of nucleation for the pairs comes about through
selection of an appropriate supersaturation, with higher values generally favouring the metastable
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polymorph. Figure 2 shows a schematic of how the values of Sme change as Sst increases from nominal
values of 3 to 7. When Sst is equal to 3 the corresponding value for Sme is 1.5 and this drives the value
of ∆G*c for the metastable polymorph above that of the stable polymorph (Equation (2)), rendering
it less favoured kinetically. When Sst is equal to 7 the critical free energy of nucleation is less for the
metastable polymorph favouring it kinetically. For the set of conditions specified in the legend to
Figure 2, most notable for the purposes of this paper C*me/C*st = 2, we predict the formation of the
stable polymorph first at Sst equal to 3 and the formation of the metastable polymorph first at Sst
equal to 7.
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Figure 2. Crystallisation pathway for a polymorph pair at the supersaturations indicated. (C*me/C*st = 2;
γst/γm = 1.45; Vm = 3.5 × 10−28 m3 molec−1).
All of these factors are gathered in Figure 3. Each of the plots in this figure is the line where the
nucleation free energy of the metastable and stable polymorphs are equal. Four lines are presented
each corresponding to a different ratio of interfacial energies. It identifies the supersaturations where
we can expect to see the initial appearance of metastable polymorphs, namely at supersaturations
above the appropriate line and where we can expect to see the initial appearance of stable polymorphs,
namely, below the appropriate line.
Based on Equation (2);
∆G∗Cme
∆G∗Cst
= (
γme
γst
)
3 ln2Sst
ln2Sme
(4)
Substituting Equation (3) yields;
∆G∗Cme
∆G∗Cst
= (
γme
γst
)
3 ln2Sst[
lnSst − ln
(
C∗me
C∗st
)]2 (5)
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For
∆G∗Cme
∆G∗Cst
= 1, one obtains
(
γst
γme
)
3
=
ln2Sst[
lnSst − ln
(
C∗me
C∗st
)]2 (6)
The domain diagram in Figure 3 is plotted according to the Equation (6).
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Figure 3. Domain diagram. For each characteristic ratios of equilibrium solubilities (C*me/C*st) and
interfacial energies (γst/γme), the plot presents the supersaturation with respect to the stable polymorph
(Sst) at which the ∆G*c values are equal. If the value for an equilibrium solubility ratio fall below its
interfacial energy ratio line then ∆G*c,st < ∆G*c,me and the stable polymorph is predicted. Conversely,
where this point falls above any interfacial energy ratio line then ∆G*c,me < ∆G*c,st and the metastable
polymorph is predicted.
Three separate factor which arise from the applied experimental conditions (Supersaturation), the
inherent properties of the polymorphism, namely the solubility ratio of the polymorph pairs (C*me/C*st)
and the ratio of solid–liquid interfacial energies (γst/γme) are covered in the domain diagram. This
diagram identifies which one of a polymorph pair, the metastable or the stable, will appear first for
a given set of experimental conditions based on the assumption that the polymorph with the lower
free energy of nucleation will appear first. In its present state the domain diagram cannot be used to
predict how rapidly the metastable to stable transformation will occur. Equally the diagram cannot be
used to predict in any way the rate of crystallisation.
The first feature of the diagram is that the domain space for the first appearance of the metastable
polymorph depends strongly on the ratio of solid–liquid interfacial energies. As this ratio increases,
caused by an increase in the solid–liquid interfacial energy for the stable polymorph or a decrease in
the corresponding value for the metastable polymorph then the domain space in which the metastable
polymorph is predicted to crystallise first, expands greatly. This is entirely understandable in terms of
the CNT which predicts that the critical free energy of nucleation and nucleation rate varies as the
exponential of third power of the solid–liquid interfacial energy term (Equation (2)). Clearly, as the
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ratio γst/γme increased the rate of nucleation of the metastable polymorph is favoured over that of the
stable polymorph widening the domain in question.
Combining this observation with the fact that we find less than 5% of polymorph pairs reviewed
by Abramov exhibit equilibrium solubility ratios in excess of 2 we must conclude that for the most part
the ratio of interfacial energies (γst/γme) should not exceed 1.5, if the metastable polymorph is to form
first at a reasonably attainable supersaturation.
Assuming that the ratios of interfacial energies and equilibrium solubilities are constant for a
given pair of polymorphs, the factor which determined which polymorph will appear first will be
the supersaturation. So, for circumstances where γst/γme is equal to 1.25 and the where C*me/C*st is
equal to 1.5 the domain diagram predicts that the critical free energy of nucleation is equal for both
polymorphs when the value of Sst is equal to 4.0. At this point the value of Sme is equal to 2.66 and
the values of the critical free energies of nucleation are equal. At higher values of Sst, for example
5.0, the corresponding value for Sme would be equal to 3.33 and this higher Sme value would drive
the critical free energy for the formation of the metastable form to a lower value than for the stable
form. Correspondingly, at a value of Sst = 3.0 the value for Sme would be 2.0 at which point the
supersaturation term in the denominator in Equation (2) for the metastable form (10 × 102 Sme) would
drive the critical free energy term to a higher value than for the stable polymorph. Interestingly,
the minimum Sme required to generate the metastable form (in the example cited above) is greater
than 2.66 and in normal circumstances that value would be higher than the metastable zone limit for
either polymorph.
For a polymorph pair where the ratio of interfacial energies (γst/γme) is 1.25 and the ratio of
solubilities C*me/C*st is 1.1 the minimum Sst required to observe the metastable polymorph first is
above 1.4 (see Figure 3 red trace); for a polymorph pair where the ratio of interfacial energies (γst/γme)
is 1.25 and the ratio of solubilities C*me/C*st is 1.5 the minimum Sst required to observe the metastable
polymorph first is above 4; for a polymorph pair where the ratio of interfacial energies (γst/γme) is
1.25 and the ratio of solubilities C*me/C*st is 1.8 the minimum Sst required to observe the metastable
polymorph first is above 8. Accordingly, the domain diagram can be used to calculate the minimum
supersaturation at which we can expect to see the metastable polymorph selected kinetically through
appropriate application of interfacial energy ratios (γst/γme) and the ratio of solubilities C*me/C*st.
Taking a polymorph pair characterised by the point where C*me/C*st is equal to 2.0, the domain
diagram predicts that when γst/γme is equal to 1.25, then the value of Sst needs to be above 20 for the
metastable polymorph to appear first. For the same equilibrium concentration ratio but where the
value of γst/γme is equal to 1.5 then Sst needs to be above 4.5 for the metastable polymorph to appear
first. Clearly, the domain diagram illustrates that for the metastable polymorphs to appear first when
the equilibrium concentration ratio is 2.0 and above, pairs need to be characterised by very high ratios
of solid liquid interfacial energies (γst/γme) or unattainably high supersaturations need to be employed.
A regular experimental finding for polymorph pairs of organic compounds is that high
supersaturations seem to favour the initial formation and in some circumstances the persistence
of the metastable form. Polymorphs pairs Eflucimibe [12], d-Mannitol [28] and Famotidine [30],
o-Aminobenzoic acid, Stavudine [31], L-Histidine [32], BPT Propyl Ester [33], Florfenicol [34] and
L-Glutamic acid [35] each of which show a preference for the stable polymorph at low supersaturations
and a preference for the metastable polymorph at higher supersaturations. Shiau used a competitive
kinetic model that predicted this behaviour for eflucimibe based on the model derived association
and dissociation rate constant for the two polymorphs [36]. More specifically, metastable Form II of
o-aminobenzoic acid was the first observed crystalline form when the supersaturation was 2 and above;
the stable Form I was the first to crystallise for supersaturations less than 1.5. The solubility ratios
were 1.2 and lower for all solvents investigated and the solutions were supersaturated with respect
to both polymorphs in all experimental conditions explored [37]. The stable Form 1 of Stavudine
crystallises at supersaturation ratios less than 2; the metastable Form 2 crystallises at ratios above 2 [31].
Metastable Form B of L-Histidine is favoured at supersaturation ratios above 2; mixtures of the stable
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(Form A) and the metastable polymorph (Form B) were reported when the supersaturation ratio was
less than 2. In this case, the supersaturation ratios were generated by suitable choice of ethanol/water
ratio and were always less than 1.5. These workers never reported a situation where the pure stable
form appeared at the lowest supersaturations employed (Sst = 1.5) but a contributing factor may have
been the very high interfacial energy values reported for the stable Form A, which were in the range
30–39 mJ m−2 [32]. Kitamura et al. [33] followed solubility changes during the crystallisation of BPT
Propyl Ester. The solubility ratio in ethanol was close to 1.5. For supersaturation above 2.2 in ethanol
the metastable polymorphs crystallise initially and the suspension exhibits the equilibrium solubility
of the metastable form. Thereafter, the metastable form transforms into the stable form via a solution
mediated mechanism. When the same crystallisation was performed at supersaturation ratios below
2.2 only the stable form appeared. It appears that the minimum supersaturation with respect to the
metastable stable polymorph required for its formation is 1.5. Values of interfacial energies were not
reported. Su et al. [38] reported that the metastable delta form of d-Mannitol forms at supersaturations
above 2.4 whereas the stable beta form was observed below 1.9, in this case the ratio of solubilities in
water was 1.4.
A further question that needs to be addressed here is the relationship with the metastable
zone width (MSZW) in kinetic selection of polymorphs. Is the MSZW a manifestation of the high
supersaturation required to form the metastable polymorph? Generally, MSZW’s are not often reported
for metastable polymorphs. Generally MSZW’s are strongly dependant on the experimental conditions
utilised in their measurement, stirring and cooling rates, but typical literature values for stable
polymorphs of organic compounds expressed as Cmszw/C*st are 1.5 for isonicotinimide [39], less than
1.1 for glycine [29], 1.5 for paracetamol [40], 2.5 for Eflucimibe [41], 1.3 for Ketoprofen [42] and 1.5 for
p-Aminobenzoic acid [43]. Similar values applied to the metastable polymorphs and expressed as a
supersaturation based on its solubility at the metastable limit Cmszw,me divided by the C*st allows us
to directly compare the predicted values with the minimum supersaturations (Sst) predicted by the
domain diagram for the kinetic selection of the metastable polymorph. Assuming that the MSZW for
the metastable polymorph is 1.5 times its solubility Table 1 compares typical Cmszw,me/C*st values with
the minimum supersaturation to achieve kinetic selection of the metastable polymorph.
Table 1. Comparison of Estimated Metastable Zone Width for the Metastable Polymorph and the Predicted
Minimum Supersaturation (Sst min) required for the Kinetic Selection of the Metastable Polymorph.
γst/γme C*me/C*st Sst min (C/C*st) Cmszw,me/C*st
1.1
1.09 1.8 1.63
1.15 3.7 1.7
1.33 8.0 2.0
1.25
1.2 2 1.8
1.5 4 2.3
1.8 8 2.7
1.5
1.2 1.5 1.9
1.5 2.5 2.25
2 5 3
2.5 7.5 3.8
* Each entry corresponds to a separate polymorph pair characterised by its ratio of interfacial energies (γst /γme) and
ratio of equilibrium solubilities (C *me /C*st);
C∗me
C∗st
and Sst,min for each
γst
γme
in Table 1 are obtained from Figure 3.
The data in the Table 1 clearly shows that at low values of C*me/C*st the MSZW limit is similar to
the minimum supersaturation predicted for the kinetic selection of the metastable polymorph. In such
circumstances the model simply predicts that the upper limit of solubility of the metastable polymorph
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defined by the MSZW needs to be attained before the metastable polymorph can be kinetically selected.
However, as C*me/C*st increases for all values of γst/γme the divergence between the two increases such
that the minimum Sst needed to form the metastable polymorph greatly exceeds any reasonable esteem
of the upper limit of supersaturation achieved for the metastable polymorph at its MSZW limit.
In terms of continuous crystallisers a number of designs have been applied, most notable mixed
suspension, mixed product removal crystallisers (MSMPR), impinging jet reactors usually operated in
association with MSMPR crystallisers, a variety of tubular crystallisers with and without baffles and
mixers, and hot melt extrusion (HME). For the most part each of these types of reactor is capable of
operating with or without seeding in cooling, anti-solvent and reactive modes; additional features
such as ultrasound, static mixing or flow oscillations can and have been applied [44–52]. One feature
pertinent to this study relates to supersaturation. In circumstances where nucleation is relatively slow,
we can expect that the MSMPR crystallisers will operate in conditions of constant supersaturation,
perhaps close to the equilibrium solubility. In one study supersaturation of L-Glutamic acid in a
MSMPR supersaturation was allowed to vary over a wide range (Sst varied from 2 to 6 approx.). In these
circumstances, the metastable alpha polymorph was formed exclusively at high supersaturations and
the stable beta polymorph was formed low supersaturations. Interestingly the metastable polymorph
became established even in circumstances where a large seed dose of the beta polymorph had been
employed at the start of the continuous run. During a transient increase in supersaturation a small
amount of the metastable alpha polymorph crystallised and thereafter persisted as the dominant solid
phase present [53]. These results are entirely in keeping with the domain diagram developed here
(Figure 3).
4. Conclusions
The critical nucleation free energy term (∆G*c) in the CNT correctly predicts that polymorph pairs
rarely exist with equilibrium solubility ratios in excess of 2. When this value is exceeded the ∆G*c term
for the stable polymorph becomes less than the corresponding value for the metastable polymorph,
even for relatively high values of the applied supersaturation. The relative sizes of the ∆G*c are critical
in determining which one of a pair of polymorphs crystallises first. The approach taken here also
explains the often experimentally observed phenomenon where the solutions are supersaturated with
respect to both polymorphs, high supersaturation favour the metastable polymorph, intermediate
values favour concomitant polymorphism and low values favour the formation of the stable polymorph.
The very high supersaturations required to generate metastable polymorphs, especially when the
ratio interfacial energies (γst/γme) is less than 1.5, are well in excess of any reasonable estimate of the
metastable zone width for the metastable polymorph.
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